API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
https://www.fiercepharma.com/pharma/jj-agrees-40-price-cut-tuberculosis-med-sirturo-south-africa-ending-antitrust-probe
https://www.fiercepharma.com/pharma/jjs-tuberculosis-med-sirturo-lands-full-us-european-approvals-after-more-decade
https://www.jnj.com/janssen-submits-phase-3-study-data-to-the-european-medicines-agency-and-u-s-food-and-drug-administration-for-sirturo-bedaquiline
https://www.fiercepharma.com/pharma/johnson-johnson-commits-not-enforce-secondary-patents-tuberculosis-med-sirturo
https://www.fiercepharma.com/pharma/johnson-johnson-slashes-price-tuberculosis-drug-sirturo-after-relinquishing-patent
https://endpts.com/jj-loses-attempt-to-extend-patent-in-india-for-tuberculosis-drug/
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/johnson-johnson-tuberculosis-drugs-final-patent-hearing-set-for-today/articleshow/97038881.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/diabetes-patented-tb-hiv-drugs-enter-essential-list/articleshow/94185393.cms
https://endpts.com/ayahuasca-inspires-another-biotech-startup-at-atai-mylan-tb-drug-gets-green-light-in-india/
https://www.reuters.com/article/us-johnson-johnson-tuberculosis/johnson-johnson-cuts-price-of-tb-drug-bedaquiline-in-poorer-countries-idUSKBN247210
https://www.jnj.com/u-s-fda-approves-new-pediatric-formulation-of-sirturoo-bedaquiline-as-part-of-combination-therapy-to-treat-children-with-pulmonary-multidrug-resistant-tuberculosis
https://www.reuters.com/article/us-health-tb-regimen/new-tb-drug-regimen-controls-resistant-disease-in-9-of-10-cases-study-idUSKBN20S02Y?feedType=RSS&feedName=healthNews
https://www.biospectrumasia.com/news/25/14627/jj-commits-500m-investment-to-end-tb-hiv.html
https://www.prnewswire.com/news-releases/fda-approves-new-treatment-for-highly-drug-resistant-forms-of-tuberculosis-300901801.html
https://www.nasdaq.com/article/jampjs-tuberculosis-drug-gets-fda-nod-for-adolescent-patients-cm1196571
https://www.reuters.com/article/us-tb-alliance-fda/fda-advisory-panel-recommends-approval-of-tb-alliances-tuberculosis-treatment-idUSKCN1T72QP
https://www.moneycontrol.com/news/business/companies/the-bedaquiline-conundrum-why-this-tb-drug-is-creating-an-intense-debate-3358221.html
https://health.economictimes.indiatimes.com/news/hospitals/jnmc-to-provide-wonder-drug-bedaquiline-free-to-tb-patients/67280642
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/johnson-and-johnson-asked-to-cut-down-price-of-new-tb-drug/articleshow/66334298.cms
https://www.thehindu.com/opinion/op-ed/the-bedaquiline-boost/article24857412.ece
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/price-of-jjs-tb-drug-to-drop-by-more-than-half/articleshow/65484162.cms
https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/who-announces-important-changes-to-multi-drug-resistant-tb-treatment/articleshow/65444597.cms
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/johnson-and-johnson-to-offer-first-tb-drug-in-40-years-for-900/articleshow/65095087.cms
https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/jj-macleods-in-talks-for-licence-deal-of-tuberculosis-drug/articleshow/63278596.cms
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/who-invites-applications-from-drug-companies-for-pre-qualification-of-mdr-tb-drugs/articleshow/63205196.cms
http://www.genengnews.com/gen-news-highlights/jj-partners-with-indias-imtech-to-develop-new-treatments-for-tb/81254817
http://economictimes.indiatimes.com/news/industry/healthcare/biotech/pharmaceuticals/drug-to-treat-mdrtb-to-be-made-available-across-the-country-government/articleshow/58132576.cms
http://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/health-ministry-dragged-to-court-over-curbs-on-tb-drugs/articleshow/56282289.cms
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/battle-for-access-to-tuberculosis-medicine-reaches-hc/articleshow/56321031.cms
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/miracle-drug-for-resistant-tuberculosis-to-be-rolled-out-for-trial-today/articleshow/51490191.cms
http://www.reuters.com/article/us-health-tuberculosis-medicine-idUSKCN0WN1YX
http://www.mumbaimirror.com/mumbai/others/First-TB-drug-in-40-yrs-will-begin-trial-run/articleshow/49838223.cms
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dishman-gets-licence-from-johnson-johnson-to-produce-tb-drug-raw-material/articleshow/49077700.cms
http://www.in-pharmatechnologist.com/Regulatory-Safety/Exporting-to-Brazil-ANVISA-is-tough-and-hands-on-says-Kemwell